HOTH vs HOWL

Hoth Therapeutics, Inc. vs Werewolf Therapeutics, Inc. — Valuation Comparison 2026

HOTH

Biotechnology
Hoth Therapeutics, Inc.
Quality
3.9
out of 10
Value Trap
12
SAFE
Price
$1.36
Last close
Models
7/13
Active
VS

HOWL

Biotechnology
Werewolf Therapeutics, Inc.
Quality
4.1
out of 10
Value Trap
30
LOW
Price
$0.46
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType HOTH Fair ValueHOTH Upside HOWL Fair ValueHOWL Upside
Bayesian DCF Intrinsic $0.48 -64.7% $0.18 -59.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.68 -50.0% $0.05 -93.6%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HOTH vs HOWL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HOTH vs HOWL — Which Stock Is More Undervalued?

HOWL scores higher with a 4.1/10 quality rating vs HOTH's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Hoth Therapeutics, Inc. (HOTH) and Werewolf Therapeutics, Inc. (HOWL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HOTH currently trades at $1.36 with a QOC of 3.9/10, while HOWL trades at $0.46 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).